Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GRT-R902 |
| Trade Name | |
| Synonyms | mRNA-based TSNA boosting vaccine GRT-R902|GRTR902|GRT R902 |
| Drug Descriptions |
GRT-R902 is a personalized boosting cancer vaccine comprising mRNA for patient tumor-specific neoantigens, potentially resulting in increased anti-tumor immune response against neoantigen-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C156926 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + GRT-C901 + GRT-R902 + Ipilimumab | Atezolizumab GRT-C901 GRT-R902 Ipilimumab | 0 | 2 |
| GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab | GRT-C901 GRT-R902 Ipilimumab Nivolumab | 0 | 1 |
| GRT-R902 | GRT-R902 | 0 | 0 |